Skip to main content
Cell Reports Medicine logoLink to Cell Reports Medicine
. 2020 Aug 25;1(5):100080. doi: 10.1016/j.xcrm.2020.100080

Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells

Seth D Reighard, Stacey A Cranert, Kelly M Rangel, Ayad Ali, Ivayla E Gyurova, Arthur T de la Cruz-Lynch, Jasmine A Tuazon, Marat V Khodoun, Leah C Kottyan, David F Smith, Hermine I Brunner, Stephen N Waggoner
PMCID: PMC7659506  PMID: 33205070

(Cell Reports Medicine 1, 100003-1–10.e1–e8; April 21, 2020)

In the originally published version of this article, graphs in Figures 4D and 4E were inadvertently duplicated. The appropriate graph for measurement of proliferating B cells (Figure 4D) and spleen weight (Figure 4E) are included in the corrected figure. The online version of the paper has been corrected, and the errors do not affect the conclusions of this paper. The authors regret this error.

Figure 4.

Figure 4

PD-L1 CAR NK Cells Kill TFH and Suppress T-Dependent B Cell Responses (corrected)

Figure 4.

Figure 4

PD-L1 CAR NK Cells Kill TFH and Suppress T-Dependent B Cell Responses (original)


Articles from Cell Reports Medicine are provided here courtesy of Elsevier

RESOURCES